Dataset Information

Rg1 improves motor recovery after spinal cord injury by suppressing astrocytic NLRP2 inflammasome via the TLR4–MyD88–NF-κB pathway

ABSTRACT: Spinal cord injury (SCI)-induced neuroinflammation and astrocyte pyroptosis severely impede motor functional recovery. Here, we report that ginsenoside Rg1 attenuates astrocyte pyroptosis by regulating the TLR4‑MyD88‑NF‑κB signaling axis, thereby promoting functional recovery in SCI rats. RNA‑seq combined with RT‑qPCR analysis revealed that Rg1 treatment significantly downregulated the transcriptional levels of Tlr4, Myd88, and Map3k7 in primary astrocytes, and reduced the expression and nuclear translocation of downstream NF‑κB pathway phosphoproteins (p‑IKKβ, p‑p65). Collectively, our data provide a molecular framework for the neuroprotective effects of Rg1 after SCI: Rg1 inhibits TLR4‑MyD88‑IKKβ/NF‑κB signaling, downregulates NLRP2 inflammasome‑mediated astrocyte pyroptosis, thereby alleviating neuroinflammation and promoting motor functional recovery. Importantly, the RNA‑seq analysis offers global molecular evidence identifying the key transcriptional pathway (TLR4/MyD88/NF‑κB) targeted by Rg1.

ORGANISM(S): Mus musculus

PROVIDER: GSE334669 | GEO | 2026/08/15

REPOSITORIES: GEO

ACCESS DATA

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Project description:Microglial overactivation is actively involved in the pathogenesis of neurodegenerative diseases. Polo-like kinase 2 (PLK2) is a serine/threonine protein kinase associated with the regulation of synaptic plasticity and centriole duplication. Here, we identified PLK2 as an important early response gene in lipopolysaccharide (LPS)-stimulated microglial cells. Knockdown or inhibition of PLK2 remarkably attenuated LPS-induced expression of pro-inflammatory factors such as IL-1β, IL-6, COX2, TNF-α, and iNOS in microglial cells via suppressing the IKKβ-NF-κB signaling pathway. Notably, overexpression of PLK2 induced expression of pro-inflammatory factors and NF-κB transcriptional activation in the absence of inflammatory stimuli. Mechanistically, co-immunoprecipitation experiments revealed association between PLK2 and IKKβ, whereas GST pull-down assay showed no direct interaction between PLK2 and IKKβ. Proteomic analysis and in vitro kinase assay identified heat shock protein 90 alpha (HSP90α), a regulator of IKKβ activity, as a novel PLK2 substrate. Knockdown or pharmacological inhibition of HSP90α abolished PLK2-mediated activation of NF-κB transcriptional activity and microglial inflammatory activation. Furthermore, phosphoproteomic analysis pinpointed Ser252 and Ser263 on HSP90α as novel phosphorylation targets of PLK2. Subsequent functional studies demonstrated that re-expression of phosphor-dead mutation of these two phosphorylation sites on HSP90α failed to rescue the PLK2-induced activation of the NF-κB signaling. Lastly, conditional knockout of PLK2 in microglial cells dramatically ameliorated neuroinflammation and subsequent dopaminergic neuron loss in an intracranial LPS-induced mouse PD model. The present study revealed, for the first time, that PLK2 promoted microglial activation through the phosphorylation of HSP90α and subsequent activation of the IKKβ-NF-κB signaling pathway. Consequently, PLK2 emerges as a potential therapeutic target for the amelioration of neuroinflammation-related diseases.

Dataset Information

Rg1 improves motor recovery after spinal cord injury by suppressing astrocytic NLRP2 inflammasome via the TLR4–MyD88–NF-κB pathway

Dataset's files

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets